4.6 Article

Rapid and reversible enhancement of blood-brain barrier permeability using lysophosphatidic acid

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor model

Ngoc H. On et al.

JOURNAL OF NEURO-ONCOLOGY (2013)

Review Physiology

Physiological mechanisms of signal termination in biological systems

E. Ligeti et al.

ACTA PHYSIOLOGICA (2012)

Review Pharmacology & Pharmacy

Duloxetine Clinical Pharmacokinetics and Drug Interactions

Mary Pat Knadler et al.

CLINICAL PHARMACOKINETICS (2011)

Review Pharmacology & Pharmacy

LPA Receptors: Subtypes and Biological Actions

Ji Woong Choi et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)

Article Cell Biology

LPA receptor expression in the central nervous system in health and following injury

Yona Goldshmit et al.

CELL AND TISSUE RESEARCH (2010)

Review Pharmacology & Pharmacy

Biopharmaceutical drug targeting to the brain

William M. Pardridge

JOURNAL OF DRUG TARGETING (2010)

Article Hematology

Regulation of Cerebromicrovascular Permeability by Lysophosphatidic Acid

Mosharraf H. Sarker et al.

MICROCIRCULATION (2010)

Article Biochemistry & Molecular Biology

Lipid phosphate phosphohydrolase type 1 (LPP1) degrades extracellular lysophosphatidic acid in vivo

Jose L. Tomsig et al.

BIOCHEMICAL JOURNAL (2009)

Article Clinical Neurology

Characteristics of compounds that cross the blood-brain barrier

William A. Banks

BMC NEUROLOGY (2009)

Article Biochemistry & Molecular Biology

Lipid phosphate phosphatases and signaling

David N. Brindley et al.

JOURNAL OF LIPID RESEARCH (2009)

Article Pharmacology & Pharmacy

Agonist-selective mechanisms of GPCR desensitization

E. Kelly et al.

BRITISH JOURNAL OF PHARMACOLOGY (2008)

Article Biochemistry & Molecular Biology

The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor

Ken-Ichi Tabata et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)

Article Radiology, Nuclear Medicine & Medical Imaging

Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer

Lakshmi Sampath et al.

JOURNAL OF NUCLEAR MEDICINE (2007)

Article Physiology

Lysophosphatidic acid induces endothelial cell death by modulating the redox environment

Sonia Brault et al.

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)

Article Biochemistry & Molecular Biology

LPA4/p2y9/GPR23 mediates rho-dependent morphological changes in a rat neuronal cell line

Keisuke Yanagida et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Article Physiology

Rac and Rho play opposing roles in the regulation of hypoxia/reoxygenation-induced permeability changes in pulmonary artery endothelial cells

B Wojciak-Stothard et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)

Article Biochemistry & Molecular Biology

Phosphorylation and desensitization of the lysophosphatidic acid receptor LPA1

SEA Avendaño-Vázquez et al.

BIOCHEMICAL JOURNAL (2005)

Article Biochemistry & Molecular Biology

Thrombogenic and atherogenic activities of lysophosphatidic acid

W Siess et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2004)

Review Biochemistry & Molecular Biology

The ins and outs of lysophosphatidic acid signaling

WH Moolenaar et al.

BIOESSAYS (2004)

Article Neurosciences

LPA1 receptor-deficient mice have phenotypic changes observed in psychiatric disease

SM Harrison et al.

MOLECULAR AND CELLULAR NEUROSCIENCE (2003)

Review Oncology

The emerging role of lysophosphatidic acid in cancer

GB Mills et al.

NATURE REVIEWS CANCER (2003)